Skip to content

Multicenter Clinical Study for Ultrasound Classification of Tuberculous Pleurisy

Multicenter Clinical Study for Ultrasound Classification of Tuberculous Pleurisy

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023811
Enrollment
Unknown
Registered
2019-06-13
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tuberculous pleurisy

Interventions

Gold Standard:Surgery results
ultrasound&#32

Sponsors

Xi'an Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Male and female inpatient aged 15 to 70 years or older depends on the health condition; (2) patients diagnosed with tuberculous pleurisy by WS 288-2017, who received thoracoscopic or thoracotomy treatment, or suspending patients with tuberculous pleurisy, who received thoracoscopic examination; (3) the main index of lung function was > 50%; (4) no abnormality of the main organs in laboratory examination; (5) ASA anesthesia risk I to III classification, the systemic state tolerated operation risk; (6) those who are willing to undergo surgery; (7) willing to cooperate with the investigation and follow-up and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) severe and extensive pulmonary tuberculosis; (2) those who have not received regular anti-tuberculosis treatment; (3) respiratory depression, airway obstruction or tissue hypoxia; (4) lung function was significantly impaired, with major indicators such as FVC, FEV1 and MVV all <40%. (5) patients with severe extrapulmonary tuberculosis who could not be cured even after removal of pulmonary lesions; (6) complicated with other serious diseases such as diabetes, hyperthyroidism, and severe liver and kidney diseases; (7) patients with congestive heart failure or renal failure; (8) patients with history of malignant tumor and immune system diseases; (9) Parkinson's disease is severe enough to increase the likelihood of falling or endanger recovery; (10) patients with severe alzheimer's disease or other mental illness who cannot cooperate with the examination; (11) had acute myocardial infarction in the past three months; (12) systemic infected persons with obvious pulmonary infection symptoms or other poorly controlled diseases; (13) combined with poorly controlled coagulation diseases; (14) other operation schedule is affected and the operation cannot be performed; (15) pregnant or lactating women; (16) drug and/alcohol abusers; (17) participants in other clinical trials.

Design outcomes

Primary

MeasureTime frame
SEN, SPE, ACC, AUC of ROC;

Secondary

MeasureTime frame
Visceral pleural thickness;Parietal pleural thickness;

Countries

China

Contacts

Public ContactHuang Yi

Xi'an Chest Hospital

huang-yi-1980@163.com+86 13319184133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026